Cat Eye Syndrome Chromosome Region, Candidate 2 (CECR2) (N-Term) Peptide
CECR2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CECR2 products
- CECR2 (Cat Eye Syndrome Chromosome Region, Candidate 2 (CECR2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SLSRESEGQK NVSSIPGKTG KRRGRPPKRK KLQEEILLSE KQEENSLASE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- CECR2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CECR2 (Cat Eye Syndrome Chromosome Region, Candidate 2 (CECR2))
- Synonyms
- CECR2 Peptide, CECR2, histone acetyl-lysine reader Peptide, cat eye syndrome chromosome region, candidate 2 Peptide, cat eye syndrome critical region protein 2 Peptide, CECR2 Peptide, cecr2 Peptide, LOC100356626 Peptide
- Background
-
This gene encodes a bromodomain-containing protein that is involved in chromatin remodeling, and may additionally play a role in DNA damage response. The encoded protein functions as part of an ATP-dependent complex that is involved in neurulation. This gene is a candidate gene for Cat Eye Syndrome. Alternative splicing results in multiple transcript variants.
Protein Size: 1484 - Gene ID
- 27443
- NCBI Accession
- NM_001290046, NP_001276975
- UniProt
- Q9BXF3
-
You are here:
